標(biāo)題：
1、Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori.
2、Removal ofcysteinylation from an unpaired sulfhydryl in the variable regionof a recombinant monoclonal IgG1 antibody improves homogeneity，stability，and biological activity
3、Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study。
4、Synthesis and biological evaluation of bis(methoxymethyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines as EGFR tyrosine kinase inhibitors.
Lee, Yong Sup; Seo, Seon Hee;Yang, Beom-Seok; Lee, Jae Yeol
Archiv der Pharmazie (Weinheim,Germany)
Volume 338 Issue 10 Pages 502-505 Journal 2005
5、Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: Synthesis of 18FIressa and related molecular probes.
Seimbille, Yann; Phelps, Michael E.; Czernin, Johannes; Silverman, Daniel H. S.
Journal of Labelled Compounds & Radiopharmaceuticals
Volume 48 Issue 11 Pages 829-843 Journal 2005
6、 Kinetic study of a 2-hydroxypropyl - -cyclodextrin-based formulation of all -trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration.
Lin HS,Chan SY,Low KS,et al. Journal of Pharmacological Sciences . 2000
7、 Design and in vivo testing of 17-beta estradial -HP beta CD sublingual tablets.
Fridriksdottir H,Loftsson T,Gudmundsson JA,et al. Pharmazie . 1996
8、 Hydroxypropyl - -cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity. Muller BW,Brauns U. Journal of Pharmacological Sciences . 1986
9、 Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Loftsson
T,Masson M,Sigurdsson HH,et al. Pharmazie . 1998
10、 Effect of 2hydroxypropyl - -cyclodextrin on percutaneous absorption
[更多]
渝公網(wǎng)安備 50010802001068號(hào)
